Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04972344
Other study ID # B-2106-688-304
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 27, 2021
Est. completion date April 11, 2022

Study information

Verified date April 2022
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The reported incidence of hypomagnesemia is approximately 2% in the general population. Hypomagnesemia is a common problem, occurring in nearly 10%of general hospitalized patients and 17% of hospitalized cancer patients. A higher incidence, up to 60% to 65%, has been found among intensive care unit patients. Hypomagnesemia can potentially cause fatal complications including ventricular arrhythmia, coronary artery spasm, and sudden death. It also associates with increased mortality and prolonged hospitalization. Magnesium exists in three different forms in the body. In serum, 5-14% of the magnesium is reported to be complexed with anions such as phosphate, bicarbonate, and citrate, 19-33% is reported to be protein-bound (mainly to albumin), and 55-67% is found in the free ionized fraction. Because the amount of bound or complexed Mg can vary significantly, especially in illness, the ionized magnesium can vary in an unpredictable way. Conventional laboratory testing typically only measures total serum magnesium, which is often not reflective of ionized magnesium. Unlike ionized calcium, which is commonly measured and is also readily calculated from the total calcium and albumin levels, ionized magnesium is neither commonly measured nor easily calculated. One study reported that the level of ionized magnesium cannot be predicted by analysis of total magnesium and that the levels of ionized magnesium vary upon different pathophysiological conditions and between individuals. Furthermore, measurement of ionized magnesium in serum might be of great impact in patients for whom magnesium status is required, and the correlation of ionized magnesium and total magnesium is weak in patients for whom magnesium status is required as a whole, and this is the reason why the ionized magnesium should be measured directly. To date, most of the clinical studies were evaluate the effect of hypomagnesemia on the outcome after surgery using the levels of total serum magnesium. However, the portion of extracellular magnesium that is physiologically active is in the various process is ionized magnesium. So, it is important to evaluate the level of ionized magnesium in surgical patients to predict the outcomes after surgery. Unfortunately, clinical trial regarding the effect of the concentrations of ionized magnesium on the surgical patients is limited.


Recruitment information / eligibility

Status Completed
Enrollment 536
Est. completion date April 11, 2022
Est. primary completion date March 18, 2022
Accepts healthy volunteers No
Gender All
Age group 19 Years to 90 Years
Eligibility Inclusion Criteria: - Patients undergoing surgery - Aged = 19 - Fasted = 8 hours Exclusion Criteria: - Chronic kidney disease - Aged < 19 - Fasted < 8 hours - Patients who were taking magnesium

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Ionized magnesium
Assessment of ionized magnesium level

Locations

Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ionized magnesium Assess the ionized magnesium level within 10 minutes after induction of anesthesia; 10 minutes before the end of surgery
Secondary total magnesium Assess the total magnesium level within 10 minutes after induction of anesthesia
See also
  Status Clinical Trial Phase
Completed NCT04130620 - Validation of the Magnesium Muscle Stretch Test
Completed NCT01593501 - How Does Magnesium Status Influence Calcium Homeostasis? Phase 4
Recruiting NCT04942119 - Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease. N/A
Recruiting NCT05149820 - Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments Phase 4
Completed NCT02032186 - A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy Phase 3
Completed NCT04216836 - One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running N/A
Completed NCT03353636 - Bioavailability of Magnesium Supplements N/A
Completed NCT02719925 - Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers N/A
Completed NCT05630339 - Magnesium and Vitamin D Combination for Post-COVID Syndrome N/A
Completed NCT03554668 - Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
Recruiting NCT05271838 - Protein and Magnesium in Ulcerative Colitis N/A
Completed NCT03134417 - Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes N/A
Active, not recruiting NCT02674789 - Ionized Magnesium in Athletes N/A
Completed NCT03466528 - Alcohol: Thiamine and or Magnesium 1 Phase 2/Phase 3
Recruiting NCT03840226 - The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients Phase 3
Terminated NCT03471481 - Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy